Panchakarma procedure and ayurvedic medicine in the management of Chittodvega w.s.r. to Generalized Anxiety Disorder
Phase 2
- Conditions
- Health Condition 1: F411- Generalized anxiety disorder
- Registration Number
- CTRI/2024/05/067679
- Lead Sponsor
- Dayanand Ayurvedic College and Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
a)Patient fulfilling diagnostic criteria for
Chittodvega w.s.r. to Generalized Anxiety
Disorder
b)Patient aged between 16-65 years.
c)Patient fit for Ghrita Pana and Pratimarsha
Nasya Karma
d)Patient of either sex
e)Patient willing to participate in the study
Exclusion Criteria
a) Age less than 16 and more than 65 years
b) Pregnant and lactating mother
c) Patient who are unfit for Ghrita Pana and
Pratimarsha Nasya Karma.
d) Patient suffering from any severe psychiatric
disorder (schizophrenia, bipolar disorder, mood
disorder) and systemic disorders like
hypertension, diabetes, hyperthyroidism,
malignancies
etc. were excluded.
e) Patients having drug dependency
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Following parameters will be assessed for the reduction in their score <br/ ><br>1.Ayasa <br/ ><br>(easy fatigability) <br/ ><br>2.Unmattachittatvama <br/ ><br>(fickle mindedness) <br/ ><br>3.Shirsha Shoonyata <br/ ><br>(feeling of emptiness in <br/ ><br>the head) <br/ ><br>4.Krodha <br/ ><br>(anger) <br/ ><br>5.Angavedana/Angamarda <br/ ><br>(body pains) <br/ ><br>6.Anidra/ Nidra nash <br/ ><br>(inability to sleep) <br/ ><br>7.Anannabhilasha <br/ ><br>(aversion of food) <br/ ><br>8.Udvega <br/ ><br>(agitation) <br/ ><br>9. Hamilton Anxiety Rating Scale <br/ ><br> <br/ ><br>Timepoint: Assessment in both the Groups will be done: <br/ ><br>Day 0 At the time of enrollment <br/ ><br>Day 15 At the end of treatment <br/ ><br>Day 30 At the time of follow up <br/ ><br> <br/ ><br>
- Secondary Outcome Measures
Name Time Method objective parameters including <br/ ><br>1. Hematological tests- Hb%, ESR <br/ ><br>2. Random Blood Sugar <br/ ><br>3. Thyroid Function TestTimepoint: Assessment will be done in both the groups: <br/ ><br>Day 0 at the time of enrollment <br/ ><br>Day 15 at the end of the treatment <br/ ><br>